Kolosis BIO Announces the Appointment of Michelle Soleimani-Mafi as Director of Operations
Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the appointment of Michelle Soleimani-Mafi as its Director of Operations.
Brandon Bloembergen
Director of Sales
Ben Christensen
Area Vice President of Sales
Michelle Soleimani-Mafi
Director of Operations
Maxwell Hunter
Chief Operating Officer
Keegan Begley
President
Collin Begley
Chief Executive Officer
Kolosis BIO Announces 2021 Results
Kolosis BIO, LLC (Kolosis), a pure-play orthobiologics company and an exclusive partner to MTF Biologics, announced today its 2021 results and 2022 expectations.
Kolosis BIO Announces Relocation of its Headquarters to Historic Salt Lake Building
Salt Lake City, Utah, – Kolosis BIO, a privately-held pure-play orthobiologics company, announced today the relocation of its global headquarters to the historic Seed Building in downtown Salt Lake City.
Kolosis BIO to Exhibit at the 2022 Montana Orthopedic Society Meeting
Kolosis BIO, a privately-held pure-play orthobiologics company, announces its support of the 2022 Montana Orthopedic Society meeting, January 14-16 at the Yellowstone Conference Center in Big Sky, Montana.